ArticleScientific reports2026
Clustering reveals diagnostic overlap between Still's disease and a hyperinflammatory subset of seronegative rheumatoid arthritis.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Still’s disease (SD) and rheumatoid arthritis (RA), particularly seronegative RA, may overlap clinically and biologically, complicating diagnosis. We explored data-driven overlaps between SD, seronegative RA, and seropositive RA using unsupervised clustering. We retrospectively included 312 adults: 98 SD from the multicentric AURAL Still cohort and 214 RA (93 seropositive, 121 seronegative). Baseline clinical and laboratory data were analysed using factor analysis of mixed data followed by k-means clustering. SD patients were younger than RA patients and more frequently presented with fever and systemic features. Inflammatory markers (notably CRP and ferritin) were higher in SD than in both RA subsets. Three clusters were identified: Cluster 1 (n = 196) mainly comprised seropositive (45%) and seronegative RA (50%), with mild systemic inflammation and symmetrical polyarthritis; Cluster 2 (n = 73) was predominantly SD (92%), with systemic features, high inflammation and polyarthritis, and more frequent spontaneous remission without treatment; Cluster 3 (n = 43) mixed SD (49%) and seronegative RA (42%), characterised by moderate inflammation and asymmetrical oligoarthritis with low autoantibody rates. Most seronegative RA clustered with classical RA, but ~ 20% overlapped with SD-like phenotypes, suggesting a hyper-inflammatory subset which could be conceptualized as Systemic Inflammatory RA (SIRA). This proposal is hypothesis-generating and warrants prospective validation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.